首页> 美国卫生研究院文献>The Indian Journal of Medical Research >CD3+ CD4+ CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast

【2h】

CD3+ CD4+ CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast

机译：CD3 +CD4 +和CD8 +肿瘤浸润淋巴细胞（TILs）是乳腺癌浸润性导管癌预后良好的预后指标

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background & objectives:Tumour infiltrating lymphocytes (TILs) represent the host immune response against cancer cells associated with good or bad prognosis in different tumour types. This study was undertaken to evaluate the significance of CD3+, CD4+ and CD8+ TILs in breast cancer tissues in relation to clinico-pathological variables and survival outcome.

机译：背景与目的：肿瘤浸润淋巴细胞（TILs）代表宿主对不同类型肿瘤预后好坏相关的癌细胞的免疫反应。进行这项研究以评估乳腺癌组织中CD3 +，CD4 +和CD8 + TIL与临床病理变量和生存结果的关系。

著录项

期刊名称 The Indian Journal of Medical Research
作者
Ankita Singh Rathore; Sandeep Kumar; Rituraj Konwar; Annu Makker; M.P.S. Negi; Madhu Mati Goel;
展开▼
作者单位

展开▼
年(卷),期 2014(140),3
年度 2014
页码 361–369
总页数 1
原文格式 PDF
正文语种
中图分类基础医学;免疫学;医学史;
关键词
Breast cancer CD3 CD4 CD8 ductal carcinoma tumour infiltrating lymphocytes;

机译：乳腺癌;CD3;CD4;CD8;导管癌;肿瘤浸润淋巴细胞;

相似文献

外文文献
中文文献
专利

1. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast. [J] . Ankita Singh Rathore, Sandeep Kumar, Rituraj Konwar, The Indian journal of medical research. . 2014,第3期

机译：CD3 +，CD4 +和CD8 +肿瘤浸润淋巴细胞（TILs）是乳腺癌浸润性导管癌预后良好的预后指标。
2. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast [J] . Ankita Singh Rathore, Sandeep Kumar, Rituraj Konwar, The Indian journal of medical research . 2014,第3期

机译：CD3 +，CD4 +和CD8 +肿瘤浸润淋巴细胞（TIL）是乳腺癌浸润性导管癌患者预后良好的预后指标
3. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast [J] . The Indian journal of medical research . 2014,第2014期

机译：CD3 +，CD4 +和CD8 +肿瘤浸润淋巴细胞（TIL）是乳腺癌浸润性导管癌患者预后良好的预后指标
4. prominent Ttamour-Infiltrating Lymphocytes Improved Disease Free Survival in Early Stage Gastric Carcinoma [C] . C. Staudacher, A. Tain burini, V. Tomajer, International Gastric Cancer Congress . 2005

机译：突出的Ttamour浸润淋巴细胞改善了早期胃癌的无病无病生存
5. Tumor Infiltrating Lymphocyte Therapy for Renal Cell Carcinoma: Methods for ex vivo Expansion and T-Cell Memory Induction [D] . Braun, Mitchell W. 2021

机译：肾细胞癌患者肿瘤浸润淋巴细胞治疗：用于脱型膨胀和T细胞记忆诱导的方法
6. Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma [O] . S Han, C Zhang, Q Li, 2014

机译：肿瘤浸润的CD4 +和CD8 +淋巴细胞可预测神经胶质瘤的临床结局
7. Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma [O] . S Han, C Zhang, Q Li, 2014

机译：肿瘤浸润CD4 +和CD8 +淋巴细胞作为胶质瘤临床结果的预测因子

CD3+ CD4+ CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast

摘要

著录项

相似文献

相关主题

期刊订阅